Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

Maurizio Zangari1, Dixie Esseltine, Choon-Kee Lee

  • 1The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. zangarimaurizio@uams.edu